Stroke therapy, spinal cord injury therapy
[更多]
First and only known biomarker for AAA Able to detect small aneurysms that evade current detecting technologies, or those initiating aneurysms evolving at molecular levels Determining plasma concentration of the biomarker is likely to be much less costly than detecting bigger aneurysms with curr.....
[更多]
Main Advantages of this InventionΓÇó UniformityΓÇó High ionic transportΓÇó Simplicity of manufacture
[更多]
None
[更多]
None
[更多]
| |< <- | [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] | -> >| |
